02-22-2009, 08:46 AM
|
#1
|
|
Senior Member
Join Date: Feb 2005
Location: Wisconsin
Posts: 159
|
NY Times article
hi everyone!
First of all, thank you so much for the birthday wishes! I haven't been on the site too much because my teenagers are time-consuming and so is my job and my masters-degree classwork! My husband and I recently separated so I'm also doing the little things around the house that John used to do.
Did you guys already talk about the article about the Zometa study that was in the NY Times? I think it was in the Thursday, Feb. 12 paper. It talked about a study about the benefits of IV Zometa; women had a lower recurrence rate after being on a course of IV Zometa.
I found it interesting because my oncologist had me on this because of my osteoporosis but now I'm thinking I'm one lucky chick to have received it. I don't recall how many doses I had though. I don't have the article in front of me but I think the schedule in the study was twice a year for three years maybe.
My apologies if this was already a thread!!!! Happy Sunday to you :-)
Val
__________________
BLOG:
http://valleygirlvnp.blogspot.com/
Dx 11/04, Age 42, ER-/PR-, HER2+++
3 months weekly Herceptin, Taxol. Carboplatin
Significant tumor shrinkage
Mastectomy 3/05; Stage 3b, 9 cm tumor, 5/8+ nodes
3 more months weekly Herceptin, Taxol. Carboplatin
7/05 30 radiation treatments, IMRT planning approach
Started 1 year of Herceptin 9/05
9/06 Began quarterly triple doses Herceptin. Brain & breast MRIs semi annually.
* * * * * * * * * * * * * * * * * * * * * * * * * * *
6/08 Right breast, intraductal carcinoma, high nuclear grade associated with comedo necrosis; extensive diffusely involved the entire biopy specimen. ER+, PR-, Her2 unknown at this point, 07/08 mastectomy.
|
|
|
Threaded Mode